The Venous Sinus System, where slow blood flow apparently predisposes to clots after the Astra-Zeneca Covid vaccination
Meryl Nass, M.D
The Astra-Zeneca “cheap and easy to store” “workhorse” vaccine causes blood clots in general, and in particular clots in the venous sinuses of the brain, which have killed or wounded a number of people, especially women under 55.
Lawyer Dr. Reiner Fuellmich, Corona Committee Foundation, demands after the public hearing of an eyewitness on the consequences of mass vaccinations: “This deadly human experiment must be stopped as soon as possible!”
Chinese health experts have now called on Norway & other countries to suspend the use of the controversial mRNA-based COVID-19 vaccine produced by companies such as Pfizer – due to safety uncertainties following the deaths of 23 elderly Norwegian people.
Watch and help us share this important video report from Friday’s edition of UK Column News…
As the Government’s bold vaccine roll-out continues, more problems emerge regarding injury and death of people who’ve taken Pfizer’s experimental mRNA genetic COVID ‘vaccine’ – prompting  China t[o] ban the jab. Meanwhile, the Government makes a power-play to censor media reporting – with the State agency now playing the role editor with major newspapers reporting COVID and lockdown, supposedly in the public interest.’ But what if the press regulator has their facts wrong? The NHS “clap” campaign seems to be bust after UKC sent its team across the country to look for any Thursday night clamour. Also, President Trump’s parting shot [at] the Democratic machine b[y] declassifying all of the FBI Russia probe document. All this and more.
Co-hosts Mike Robinson and Patrick Henningsen take a look at the end of week news round-up. Watch:
Before the COVID-19 pandemic engulfed the world, the big pharmaceutical companies did little investment in vaccines for global diseases and viruses. It was just not profitable. Of the 18 largest US pharmaceutical companies, 15 had totally abandoned the field. Heart medicines, addictive tranquilizers and treatments for male impotence were profit leaders, not defences against hospital infections, emergent diseases and traditional tropical killers. A universal vaccine for influenza—that is to say, a vaccine that targets the immutable parts of the virus’s surface proteins—has been a possibility for decades, but never deemed profitable enough to be a priority. So, every year, we get vaccines that are only 50% efficient.